se ha leído el artículo
array:22 [ "pii" => "S0001731012700029" "issn" => "00017310" "doi" => "10.1016/S0001-7310(12)70002-9" "estado" => "S300" "fechaPublicacion" => "2012-10-01" "aid" => "70002" "copyright" => "Academia Española de Dermatología y Venereología" "copyrightAnyo" => "2012" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2012;103 Supl 2:1-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1784 "formatos" => array:2 [ "HTML" => 1012 "PDF" => 772 ] ] "itemSiguiente" => array:18 [ "pii" => "S0001731012700030" "issn" => "00017310" "doi" => "10.1016/S0001-7310(12)70003-0" "estado" => "S300" "fechaPublicacion" => "2012-10-01" "aid" => "70003" "copyright" => "Academia Española de Dermatología y Venereología" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2012;103 Supl 2:7-15" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2317 "formatos" => array:2 [ "HTML" => 1150 "PDF" => 1167 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Mecanismo de acción de ustekinumab y su relevancia en la patogénesis de la psoriasis. Impacto en el sistema inmune" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "7" "paginaFinal" => "15" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Mechanism of Action of Ustekinumab and its Relevance in the Pathogenesisof Psoriasis. Impact on the Immune System" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J.M. Carrascosa" "autores" => array:1 [ 0 => array:2 [ "nombre" => "J.M." "apellidos" => "Carrascosa" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731012700030?idApp=UINPBA000044" "url" => "/00017310/00000103000000S2/v1_201304241722/S0001731012700030/v1_201304241722/es/main.assets" ] "es" => array:12 [ "idiomaDefecto" => true "titulo" => "Ustekinumab. Introducción. Estructura química. Farmacocinética e inmunogenicidad" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "1" "paginaFinal" => "6" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "E. Daudén" "autores" => array:1 [ 0 => array:3 [ "nombre" => "E." "apellidos" => "Daudén" "email" => array:1 [ 0 => "estebandauden@medynet.com" ] ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Servicio de Dermatología. Hospital Universitario de la Princesa. Madrid. España" ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Ustekinumab. Introduction. Chemical Structure. Pharmacokinetics and immunogenicity" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec85078" "palabras" => array:7 [ 0 => "Ustekinumab" 1 => "Interleucina 12" 2 => "Interleucina 23" 3 => "Terapia biológica" 4 => "Psoriasis" 5 => "Enfermedad de Crohn" 6 => "Farmacocinética" ] ] ] "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec85079" "palabras" => array:7 [ 0 => "Ustekinumab" 1 => "Interleukin 12" 2 => "Interleukin 23" 3 => "Biologic therapy" 4 => "Psoriasis" 5 => "Crohn disease" 6 => "Pharmacokinetics" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Se presenta el contenido de esta monografía sobre el conocimiento actual del ustekinumab, especialmente en relación con la psoriasis pero también en otras indicaciones. Se describe su estructura química, el proceso de obtención, se analizan los datos farmacocinéticos (absorción, distribución, metabolismo, eliminación), sus interacciones y se revisa la información relativa a la inmunogenicidad de la molécula.</p>" ] "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">This chapter opens with a brief introduction to the content of this supplement summarizing our current knowledge of ustekinumab with a particular focus on psoriasis but also including other indications. In addition to describing the chemical structure and the process used to produce this biologic agent, the chapter analyzes the drug's pharmacokinetic profile (absorption, distribution, metabolism, and excretion) and interactions with other drugs. A review of the information relating to the immunogenicity of the molecule is also included.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Bibliografía" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:24 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Psoriasis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "F.O. Nestle" 1 => "D.H. Kaplan" 2 => "J. Barker" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMra0804595" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2009" "volumen" => "361" "paginaInicial" => "496" "paginaFinal" => "509" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19641206" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "National Psoriasis Foundation National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.B. Kimball" 1 => "D. Gladman" 2 => "J.M. Gelfand" 3 => "K. Gordon" 4 => "E.J. Horn" 5 => "N.J. Korman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2008.01.006" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2008" "volumen" => "58" "paginaInicial" => "1031" "paginaFinal" => "1042" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18313171" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R.S. Stern" 1 => "T. Nijsten" 2 => "S.R. Feldman" 3 => "D.J. Margolis" 4 => "T. Rolstad" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1046/j.1087-0024.2003.09102.x" "Revista" => array:6 [ "tituloSerie" => "J Investig Dermatol Symp Proc" "fecha" => "2004" "volumen" => "9" "paginaInicial" => "136" "paginaFinal" => "139" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15083780" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Ustekinumab SPC. (Acceso en Ago 2011). Disponible en: <a class="elsevierStyleInterRef" href="http://www.emea.europe.eu/humandocs/PDFs/EPAR/stelara/H-958-PI-en.pdf">http://www.emea.europe.eu/humandocs/PDFs/EPAR/stelara/H-958-PI-en.pdf</a>)." ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Ustekinumab Crohn's Disease Study Group" "etal" => true "autores" => array:6 [ 0 => "W.J. Sandborn" 1 => "B.G. Feagan" 2 => "R.N. Fedorak" 3 => "E. Scherl" 4 => "M.R. Fleisher" 5 => "S. Katz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.gastro.2008.07.014" "Revista" => array:6 [ "tituloSerie" => "Gastroenterology" "fecha" => "2008" "volumen" => "135" "paginaInicial" => "1130" "paginaFinal" => "1141" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18706417" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ustekinumab, a human interleukin-12/23 monoclonal antibody, for psoriatic arthritis: randomized, double-blind, placebo-controlled, crossover trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Gottlieb" 1 => "A. Menter" 2 => "A. Mendelsohn" 3 => "Y.K. Shen" 4 => "S. Li" 5 => "C. Guzzo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(09)60140-9" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2009" "volumen" => "373" "paginaInicial" => "633" "paginaFinal" => "640" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19217154" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A phase I trial of an interleukin-12/23 monoclonal antibody in relapsing multiple sclerosis" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Multiple Sclerosis Investigators" "etal" => true "autores" => array:6 [ 0 => "L.H. Kasper" 1 => "D. Everitt" 2 => "T.P. Leist" 3 => "K.A. Ryan" 4 => "M.A. Mascelli" 5 => "K. Johnson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1185/030079906X120931" "Revista" => array:6 [ "tituloSerie" => "Curr Med Res Opin" "fecha" => "2006" "volumen" => "22" "paginaInicial" => "1671" "paginaFinal" => "1678" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16968570" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomized, dose-ranging study" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Ustekinumab MS Investigators" "etal" => false "autores" => array:6 [ 0 => "B.M. Segal" 1 => "C.S. Constantinescu" 2 => "A. Raychaudhuri" 3 => "L. Kim" 4 => "R. Fidelus-Gort" 5 => "L.H. Kasper" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1474-4422(08)70173-X" "Revista" => array:6 [ "tituloSerie" => "Lancet Neurol" "fecha" => "2008" "volumen" => "7" "paginaInicial" => "796" "paginaFinal" => "804" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18703004" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.M. Fishwild" 1 => "S.L. O’Donnell" 2 => "T. Bengoechea" 3 => "D.V. Hudson" 4 => "F. Harding" 5 => "S.L. Bernhard" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nbt0796-845" "Revista" => array:6 [ "tituloSerie" => "Nat Biotechnol" "fecha" => "1996" "volumen" => "14" "paginaInicial" => "845" "paginaFinal" => "851" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9631008" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "N. Yeilding" 1 => "P. Szapary" 2 => "C. Brodmerkel" 3 => "J. Benson" 4 => "M. Plotnick" 5 => "H. Zhou" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1749-6632.2011.05963.x" "Revista" => array:6 [ "tituloSerie" => "Ann N Y Acad Sci" "fecha" => "2011" "volumen" => "1222" "paginaInicial" => "30" "paginaFinal" => "39" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21434940" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.M. Benson" 1 => "C.W. Sachs" 2 => "G. Treacy" 3 => "H. Zhou" 4 => "C.E. Pendley" 5 => "C.M. Brodmerkel" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nbt.1903" "Revista" => array:6 [ "tituloSerie" => "Nat Biotechnol" "fecha" => "2011" "volumen" => "29" "paginaInicial" => "615" "paginaFinal" => "624" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21747388" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Population pharmacokinetic modeling of ustekinumab, a human monoclonal antibody targeting IL-12/23p40, in patients with moderate to severe plaque psoriasis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Y. Zhu" 1 => "C. Hu" 2 => "M. Lu" 3 => "S. Liao" 4 => "J.C. Marini" 5 => "J. Yohrling" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0091270008329556" "Revista" => array:6 [ "tituloSerie" => "J Clin Pharmacol" "fecha" => "2009" "volumen" => "49" "paginaInicial" => "162" "paginaFinal" => "175" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19179295" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Population pharmacokinetics of ustekinumab in patients with active psoriatic arthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Y.W. Zhu" 1 => "A. Mendelsohn" 2 => "C. Pendley" 3 => "H.M. Davis" 4 => "H. Zhou" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Int J Clin Pharmacol Ther" "fecha" => "2010" "volumen" => "48" "paginaInicial" => "830" "paginaFinal" => "846" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21084039" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ustekinumab for the treatment of plaque psoriasis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "K. Reich" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Expert Rev Dermatol" "fecha" => "2009" "volumen" => "4" "paginaInicial" => "443" "paginaFinal" => "453" ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A phase 1, double-blind, placebo-controlled study evaluating single subcutaneous administrations of a human interleukin-12/23 monoclonal antibody in subjects with plaque psoriasis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.B. Gottlieb" 1 => "K.D. Cooper" 2 => "T.S. McCormick" 3 => "E. Toichi" 4 => "D.E. Everitt" 5 => "B. Frederick" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1185/030079907X182112" "Revista" => array:6 [ "tituloSerie" => "Curr Med Res Opin" "fecha" => "2007" "volumen" => "23" "paginaInicial" => "1081" "paginaFinal" => "1092" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17519075" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Transcytosis and catabolism of antibody" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "V. Ghetie" 1 => "E.S. Ward" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1385/IR:25:2:097" "Revista" => array:6 [ "tituloSerie" => "Immunol Res" "fecha" => "2002" "volumen" => "25" "paginaInicial" => "97" "paginaFinal" => "113" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11999172" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: rationale for dosing recommendations" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Lebwohl" 1 => "N. Yeilding" 2 => "P. Szapary" 3 => "Y. Wang" 4 => "S. Li" 5 => "Y. Zhu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2009.11.012" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2010" "volumen" => "63" "paginaInicial" => "571" "paginaFinal" => "579" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20599293" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Population-based assessments of clinical drug-drug interactions: qualitative indices or quantitative measures?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "H. Zhou" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0091270006294278" "Revista" => array:6 [ "tituloSerie" => "J Clin Pharmacol" "fecha" => "2006" "volumen" => "46" "paginaInicial" => "1268" "paginaFinal" => "1289" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17050792" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk-based strategy for the assessment of pharmacokinetic drug-drug interactions for therapeutic monoclonal antibodies" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "H. Zhou" 1 => "H.M. Davis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.drudis.2009.05.014" "Revista" => array:6 [ "tituloSerie" => "Drug Discov Today" "fecha" => "2009" "volumen" => "14" "paginaInicial" => "891" "paginaFinal" => "898" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19520183" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 1)" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "PHOENIX 1 study investigators" "etal" => true "autores" => array:6 [ 0 => "C.L. Leonardi" 1 => "A.B. Kimball" 2 => "K.A. Papp" 3 => "N. Yeilding" 4 => "C. Guzzo" 5 => "Y. Wang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(08)60725-4" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2008" "volumen" => "371" "paginaInicial" => "1665" "paginaFinal" => "1674" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18486739" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 2)" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "PHOENIX 2 study investigators" "etal" => true "autores" => array:6 [ 0 => "K.A. Papp" 1 => "R.G. Langley" 2 => "M. Lebwohl" 3 => "G.G. Krueger" 4 => "P. Szapary" 5 => "N. Yeilding" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(08)60726-6" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2008" "volumen" => "371" "paginaInicial" => "1675" "paginaFinal" => "1684" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18486740" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib22" "etiqueta" => "22." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "ACCEPT Study Group" "etal" => true "autores" => array:6 [ 0 => "C.E. Griffiths" 1 => "B.E. Strober" 2 => "P. Van de Kerkhof" 3 => "V. Ho" 4 => "R. Fidelus-Gort" 5 => "N. Yeilding" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa0810652" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2010" "volumen" => "362" "paginaInicial" => "118" "paginaFinal" => "128" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20071701" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib23" "etiqueta" => "23." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.L. Kauffman" 1 => "N. Aria" 2 => "E. Toichi" 3 => "T.S. McCormick" 4 => "K.D. Cooper" 5 => "A.B. Gottlieb" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.0022-202X.2004.23448.x" "Revista" => array:6 [ "tituloSerie" => "J Invest Dermatol" "fecha" => "2004" "volumen" => "123" "paginaInicial" => "1037" "paginaFinal" => "1044" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15610511" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib24" "etiqueta" => "24." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "CNTO 1275 Psoriasis Study Group" "etal" => true "autores" => array:6 [ 0 => "G.G. Krueger" 1 => "R.G. Langley" 2 => "C. Leonardi" 3 => "N. Yeilding" 4 => "C. Guzzo" 5 => "Y. Wang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa062382" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2007" "volumen" => "356" "paginaInicial" => "580" "paginaFinal" => "592" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17287478" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/00017310/00000103000000S2/v1_201304241722/S0001731012700029/v1_201304241722/es/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/00017310/00000103000000S2/v1_201304241722/S0001731012700029/v1_201304241722/es/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731012700029?idApp=UINPBA000044" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 2 | 8 | 10 |
2024 Octubre | 37 | 41 | 78 |
2024 Septiembre | 36 | 31 | 67 |
2024 Agosto | 61 | 54 | 115 |
2024 Julio | 38 | 31 | 69 |
2024 Junio | 46 | 31 | 77 |
2024 Mayo | 37 | 32 | 69 |
2024 Abril | 40 | 25 | 65 |
2024 Marzo | 41 | 35 | 76 |
2024 Febrero | 23 | 39 | 62 |
2024 Enero | 40 | 46 | 86 |
2023 Diciembre | 40 | 46 | 86 |
2023 Noviembre | 37 | 19 | 56 |
2023 Octubre | 31 | 17 | 48 |
2023 Septiembre | 35 | 18 | 53 |
2023 Agosto | 31 | 21 | 52 |
2023 Julio | 24 | 32 | 56 |
2023 Junio | 35 | 25 | 60 |
2023 Mayo | 23 | 17 | 40 |
2023 Abril | 32 | 19 | 51 |
2023 Marzo | 29 | 28 | 57 |
2023 Febrero | 27 | 8 | 35 |
2023 Enero | 25 | 23 | 48 |
2022 Diciembre | 28 | 26 | 54 |
2022 Noviembre | 19 | 33 | 52 |
2022 Octubre | 27 | 17 | 44 |
2022 Septiembre | 22 | 29 | 51 |
2022 Agosto | 21 | 38 | 59 |
2022 Julio | 17 | 37 | 54 |
2022 Junio | 26 | 20 | 46 |
2022 Mayo | 28 | 34 | 62 |
2022 Abril | 37 | 39 | 76 |
2022 Marzo | 28 | 48 | 76 |
2022 Febrero | 28 | 19 | 47 |
2022 Enero | 30 | 46 | 76 |
2021 Diciembre | 28 | 35 | 63 |
2021 Noviembre | 48 | 49 | 97 |
2021 Octubre | 37 | 48 | 85 |
2021 Septiembre | 34 | 37 | 71 |
2021 Agosto | 31 | 43 | 74 |
2021 Julio | 17 | 38 | 55 |
2021 Junio | 41 | 42 | 83 |
2021 Mayo | 31 | 36 | 67 |
2021 Abril | 62 | 49 | 111 |
2021 Marzo | 68 | 45 | 113 |
2021 Febrero | 37 | 26 | 63 |
2021 Enero | 26 | 18 | 44 |
2020 Diciembre | 33 | 17 | 50 |
2020 Noviembre | 22 | 14 | 36 |
2020 Octubre | 30 | 21 | 51 |
2020 Septiembre | 16 | 13 | 29 |
2020 Agosto | 22 | 23 | 45 |
2020 Julio | 16 | 20 | 36 |
2020 Junio | 27 | 17 | 44 |
2020 Mayo | 37 | 40 | 77 |
2020 Abril | 23 | 19 | 42 |
2020 Marzo | 27 | 21 | 48 |
2020 Febrero | 3 | 5 | 8 |
2019 Diciembre | 0 | 2 | 2 |
2019 Octubre | 0 | 1 | 1 |
2019 Septiembre | 0 | 1 | 1 |
2019 Agosto | 0 | 5 | 5 |
2019 Julio | 0 | 11 | 11 |
2019 Junio | 0 | 21 | 21 |
2019 Mayo | 0 | 72 | 72 |
2019 Abril | 0 | 28 | 28 |
2019 Marzo | 0 | 14 | 14 |
2019 Febrero | 0 | 7 | 7 |
2019 Enero | 0 | 5 | 5 |
2018 Diciembre | 0 | 6 | 6 |
2018 Noviembre | 0 | 2 | 2 |
2018 Octubre | 0 | 4 | 4 |
2018 Septiembre | 0 | 1 | 1 |
2018 Agosto | 0 | 2 | 2 |
2018 Julio | 0 | 7 | 7 |
2018 Junio | 0 | 1 | 1 |
2018 Mayo | 0 | 9 | 9 |
2018 Marzo | 1 | 3 | 4 |
2018 Febrero | 22 | 5 | 27 |
2018 Enero | 16 | 4 | 20 |
2017 Diciembre | 31 | 9 | 40 |
2017 Noviembre | 35 | 11 | 46 |
2017 Octubre | 17 | 4 | 21 |
2017 Septiembre | 20 | 15 | 35 |
2017 Agosto | 17 | 7 | 24 |
2017 Julio | 12 | 3 | 15 |
2017 Junio | 28 | 5 | 33 |
2017 Mayo | 28 | 11 | 39 |
2017 Abril | 32 | 13 | 45 |
2017 Marzo | 38 | 23 | 61 |
2017 Febrero | 34 | 10 | 44 |
2017 Enero | 49 | 15 | 64 |
2016 Diciembre | 60 | 11 | 71 |
2016 Noviembre | 25 | 9 | 34 |
2016 Octubre | 24 | 14 | 38 |
2016 Septiembre | 33 | 24 | 57 |
2016 Agosto | 45 | 16 | 61 |
2016 Julio | 40 | 25 | 65 |
2016 Junio | 0 | 27 | 27 |
2016 Mayo | 0 | 18 | 18 |
2016 Abril | 0 | 2 | 2 |
2016 Marzo | 3 | 1 | 4 |
2016 Febrero | 2 | 0 | 2 |
2016 Enero | 0 | 48 | 48 |
2015 Diciembre | 1 | 18 | 19 |
2015 Noviembre | 5 | 17 | 22 |
2015 Octubre | 2 | 0 | 2 |
2015 Septiembre | 7 | 10 | 17 |
2015 Agosto | 9 | 8 | 17 |
2015 Julio | 38 | 2 | 40 |
2015 Junio | 40 | 9 | 49 |
2015 Mayo | 44 | 16 | 60 |
2015 Abril | 51 | 22 | 73 |
2015 Marzo | 27 | 12 | 39 |
2015 Febrero | 37 | 16 | 53 |
2015 Enero | 26 | 20 | 46 |
2014 Diciembre | 38 | 20 | 58 |
2014 Noviembre | 34 | 18 | 52 |
2014 Octubre | 32 | 38 | 70 |
2014 Septiembre | 0 | 1 | 1 |
2014 Agosto | 2 | 0 | 2 |
2014 Julio | 0 | 1 | 1 |
2014 Mayo | 1 | 0 | 1 |
2014 Enero | 1 | 1 | 2 |
2013 Noviembre | 0 | 1 | 1 |
2013 Septiembre | 0 | 1 | 1 |
2013 Julio | 0 | 1 | 1 |
2013 Junio | 3 | 3 | 6 |
2013 Mayo | 1 | 2 | 3 |
2013 Abril | 1 | 1 | 2 |
2013 Febrero | 0 | 1 | 1 |
2013 Enero | 0 | 1 | 1 |